A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of giving HIV-infected
patients delavirdine (DLV) plus zidovudine (ZDV) plus 2 doses of indinavir (IDV) or ZDV plus
IDV plus lamivudine (3TC). This study also examines how the body processes DLV when it is
given in combination with other drugs.